Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients

NCT01612078 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Orthostatic Hypotension

Interventions

DRUG: Droxidopa
DRUG: Placebo

Sponsor

TSH Biopharm Corporation Limited